CLS participates with hands-on workshop at the European Conference on Interventional Oncology, 20-24 April, in Vienna

Clinical Laserthermia Systems (CLS) (publ), participates at ECIO in Vienna, Austria, 20-24 April. CLS demonstrates the TRANBERG®|Thermal Therapy System to interested doctors and other medical professionals in a hands-on workshop. The purpose with ECIO’s hand-on workshops is that various industry representatives, in an educational format, can showcase and share knowledge, data and experience in various medical areas and possibly find ways to collaborations or synergies. 

The first ECIO meeting took place in 2008, and since 2012 ECIO is a yearly event targeting experts in interventional oncology, which means interventional radiology with focus on new methods for cancer treatment. These include less invasive treatment methods compared to traditional surgery and are carried out in an image guided process using for example computer tomography (CT), magnetic resonance imaging (MRI) or Ultra Sound (US) 

CLS is a member of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) who arranges the conference, which usually attracts more than 1000 delegates from about 50 countries. 

CLS is in booth # 5. Read more about ECIO 

Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 – (0)702 – 90 33 00   E-mail:

Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and have subsidiaries in Berlin, Germany and Boston, MA,USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s website: